Labcorp to Present at the Jefferies Global Healthcare Conference
Rhea-AI Summary
Labcorp (NYSE: LH) announced it will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET.
Investors can access a live webcast and a recorded archive for 90 days on Labcorp's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – LH
In the May 27 session, LH declined 0.08%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 20 | Product/AI launch | Positive | +0.6% | Launch of MyLabcorp™ AI-powered app for lab results and health trends. |
| May 12 | Partnership expansion | Positive | +0.9% | Expanded Epic collaboration to integrate full Labcorp test menu in Aura. |
| May 01 | Corporate structuring | Neutral | -0.4% | Knoa Pharma begins operations as public health–focused subsidiary entity. |
| Apr 30 | Earnings and guidance | Positive | -0.1% | Q1 2026 beat with revenue, EPS growth and raised full-year guidance. |
| Apr 22 | Diagnostic launch | Positive | -0.8% | Launch of FDA-approved PD-L1 companion diagnostic for KEYTRUDA eligibility. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news with clearly positive fundamentals or partnerships has often seen modest positive reactions, while strong earnings and product launches have occasionally met with mild selling pressure.
Over the past two months, Labcorp reported multiple developments, including an AI-powered MyLabcorp™ app on May 20, 2026 and an expanded Epic collaboration on May 12, 2026, both followed by small share gains. Q1 2026 results on April 30, 2026 showed revenue of $3.54B and raised guidance but drew a slight negative reaction. A new FDA-approved ovarian cancer companion diagnostic on April 22, 2026 also saw a modest share decline. Today’s conference appearance fits into this steady news flow without adding new financial metrics.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The presentation can be accessed via a live webcast on the Labcorp Investor Relations website at ir.labcorp.com. An archived, recorded version of the session will be available approximately 24 hours after the session ends and can be accessed for 90 days following the event.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-present-at-the-jefferies-global-healthcare-conference-302782438.html
SOURCE Labcorp Holdings Inc